Propel Bio Management as of June 30, 2024
Portfolio Holdings for Propel Bio Management
Propel Bio Management holds 24 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Applied Therapeutics Comm (APLT) | 19.9 | $31M | 6.6M | 4.67 | |
| Plains Gp Holdings Lp-cl Comm (PAGP) | 16.8 | $26M | 1.4M | 18.82 | |
| Tscan Therapeutics Comm (TCRX) | 7.9 | $12M | 2.1M | 5.85 | |
| Madrigal Pharmaceuticals Comm (MDGL) | 7.8 | $12M | 43k | 280.16 | |
| Achieve Life Sciences Comm (ACHV) | 7.5 | $12M | 2.5M | 4.70 | |
| Phathom Pharmaceuticals I Comm (PHAT) | 5.8 | $9.0M | 870k | 10.30 | |
| Akero Therapeutics Comm (AKRO) | 5.0 | $7.7M | 328k | 23.46 | |
| Avidity Biosciences Comm (RNA) | 4.7 | $7.3M | 179k | 40.85 | |
| Ardelyx Comm (ARDX) | 4.4 | $6.9M | 925k | 7.41 | |
| Abeona Therapeutics Comm (ABEO) | 3.4 | $5.3M | 1.2M | 4.24 | |
| Fulcrum Therapeutics Comm (FULC) | 3.0 | $4.7M | 750k | 6.20 | |
| Athira Pharma Comm (ATHA) | 2.6 | $4.0M | 1.5M | 2.65 | |
| Telesat Corp Comm (TSAT) | 2.2 | $3.3M | 366k | 9.10 | |
| Verrica Pharmaceuticals I Comm | 2.0 | $3.1M | 425k | 7.29 | |
| Kura Oncology Comm (KURA) | 1.7 | $2.7M | 130k | 20.59 | |
| Eiger Biopharmaceuticals Comm | 1.2 | $1.9M | 146k | 12.65 | |
| Syndax Pharmaceuticals In Comm (SNDX) | 1.1 | $1.7M | 83k | 20.53 | |
| Kymera Therapeutics Comm (KYMR) | 1.1 | $1.7M | 56k | 29.85 | |
| Kayne Anderson Energy Inf Comm (KYN) | 1.0 | $1.5M | 147k | 10.33 | |
| Trevi Therapeutics Comm (TRVI) | 0.5 | $775k | 260k | 2.98 | |
| Fidelity Inv Mmtrsy 1 680 Comm | 0.2 | $317k | 317k | 1.00 | |
| Cybin Comm | 0.1 | $230k | 850k | 0.27 | |
| Maat Pharma Saca Comm | 0.0 | $9.8k | 1.4k | 7.16 | |
| Chinook Therapeutics Comm | 0.0 | $9.8k | 79k | 0.12 |
